UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Artemis Investment Management LLP

Artemis Investment Management LLP trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 65.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,476 shares of the healthcare conglomerate's stock after selling 40,981 shares during the period. Artemis Investment Management LLP's holdings in UnitedHealth Group were worth $10,864,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of UNH. State Street Corp lifted its holdings in shares of UnitedHealth Group by 1.3% in the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after buying an additional 563,554 shares during the period. Geode Capital Management LLC lifted its stake in UnitedHealth Group by 1.6% in the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock worth $11,440,133,000 after acquiring an additional 318,039 shares during the period. Franklin Resources Inc. raised its holdings in shares of UnitedHealth Group by 2.5% in the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock valued at $4,884,019,000 after purchasing an additional 193,800 shares in the last quarter. International Assets Investment Management LLC grew its stake in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its position in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock worth $1,920,039,000 after purchasing an additional 21,149 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Down 0.1 %

NYSE:UNH traded down $0.56 during trading hours on Monday, hitting $510.03. The company had a trading volume of 7,462,712 shares, compared to its average volume of 5,104,531. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a 50-day moving average of $549.37 and a 200 day moving average of $563.70. The company has a market cap of $469.37 billion, a P/E ratio of 33.23, a P/E/G ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the company posted $5.83 EPS. The business's revenue for the quarter was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. UnitedHealth Group's payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on UNH. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Cantor Fitzgerald reissued an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday. HSBC raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target on the stock in a report on Friday, January 10th. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Finally, Barclays reduced their target price on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research note on Friday. Two equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Buy" and a consensus target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.